IgG cryoglobulinemia

Eur Rev Med Pharmacol Sci. 2018 Sep;22(18):6057-6062. doi: 10.26355/eurrev_201809_15943.

Abstract

Objective: Mixed Cryoglobulinemia is the most well-known Hepatitis C Virus (HCV)-associated extrahepatic manifestation. MC is both an autoimmune and B-lymphoproliferative disorder. Cryoglobulins (CGs) are classified into three groups according to immunoglobulin (Ig) composition: type I is composed of one isotype or Ig class. Type II and type III mixed CGs are immune complexes composed of polyclonal IgGs acting as autoantigens and mono, polyclonal or oligoclonal IgM with rheumatoid factor activity. IgG1 and IgG3 are the predominant subclasses involved. This study shows the simultaneous presence of IgG-RF and IgG3, supporting the hypothesis of an involvement of this subclass in the initiation of early stages of CGs.

Patients and methods: We describe a case series of six HCV-positive patients, all of whom had peripheral neuropathy and transient ischemic attacks, presenting cryoprecipitates formed by IgG3 and IgG1. Cryoprecipitate IgG subclass research was carried out by immunofixation electrophoresis by using antisera against IgG1, IgG2, IgG3, and IgG4.

Results: Our six patients presented with an immunochemical pattern characterized by the mere presence of IgG1 and IgG3 subclasses with probable RF activity and one of these six patients exhibited monoclonal IgG3 in his cerebrospinal fluid.

Conclusions: We can hypothesize that the IgG passage through the blood-brain barrier could have contributed to the cause of TIAs, through a mechanism involving the precipitation of circulating immune complexes formed by the two subclasses in the intrathecal vessels.

Publication types

  • Observational Study

MeSH terms

  • Aged
  • Blood-Brain Barrier / immunology
  • Cryoglobulinemia / etiology
  • Cryoglobulinemia / immunology*
  • Female
  • Hepatitis C / complications*
  • Hepatitis C / immunology
  • Humans
  • Immunoglobulin G / classification*
  • Immunoglobulin G / metabolism
  • Male
  • Middle Aged
  • Peripheral Nervous System Diseases / etiology*
  • Peripheral Nervous System Diseases / immunology
  • Rheumatoid Factor / metabolism

Substances

  • Immunoglobulin G
  • Rheumatoid Factor